These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22778851)

  • 21. Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination.
    Klein AN; Ziehm T; Tusche M; Buitenhuis J; Bartnik D; Boeddrich A; Wiglenda T; Wanker E; Funke SA; Brener O; Gremer L; Kutzsche J; Willbold D
    PLoS One; 2016; 11(4):e0153035. PubMed ID: 27105346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of NK-4 in a transgenic mouse model of Alzheimer's disease.
    Ohta H; Arai S; Akita K; Ohta T; Fukuda S
    PLoS One; 2012; 7(1):e30007. PubMed ID: 22238689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver.
    Sehgal N; Gupta A; Valli RK; Joshi SD; Mills JT; Hamel E; Khanna P; Jain SC; Thakur SS; Ravindranath V
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3510-5. PubMed ID: 22308347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aβ oligomer eliminating compounds interfere successfully with pEAβ(3-42) induced motor neurodegenerative phenotype in transgenic mice.
    Dunkelmann T; Teichmann K; Ziehm T; Schemmert S; Frenzel D; Tusche M; Dammers C; Jürgens D; Langen KJ; Demuth HU; Shah NJ; Kutzsche J; Willuweit A; Willbold D
    Neuropeptides; 2018 Feb; 67():27-35. PubMed ID: 29273382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
    Tweedie D; Ferguson RA; Fishman K; Frankola KA; Van Praag H; Holloway HW; Luo W; Li Y; Caracciolo L; Russo I; Barlati S; Ray B; Lahiri DK; Bosetti F; Greig NH; Rosi S
    J Neuroinflammation; 2012 May; 9():106. PubMed ID: 22642825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.
    Schartmann E; Schemmert S; Niemietz N; Honold D; Ziehm T; Tusche M; Elfgen A; Gering I; Brener O; Shah NJ; Langen KJ; Kutzsche J; Willbold D; Willuweit A
    J Alzheimers Dis; 2018; 64(3):859-873. PubMed ID: 29966196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
    Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
    Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques.
    Kim HY; Kim HV; Jo S; Lee CJ; Choi SY; Kim DJ; Kim Y
    Nat Commun; 2015 Dec; 6():8997. PubMed ID: 26646366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.